Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Magistral Biotech is a Spanish pharmaceutical company specializing in the research, development, and production of cannabinoid-based medicines and active pharmaceutical ingredients (APIs). The company operates under strict Good Manufacturing Practice (GMP) standards to provide standardized medical cannabis extracts, including THC and CBD formulations, for therapeutic applications. Their business model focuses on the pharmaceutical-grade supply chain, from cultivation and extraction to the formulation of magistral preparations. Magistral Biotech serves the medical community by providing clinicians with reliable, high-quality cannabinoid therapies for conditions such as chronic pain, spasticity in multiple sclerosis, and refractory epilepsy. The company is a key player in the emerging European medical cannabis market, bridging the gap between botanical products and pharmaceutical standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Magistral Biotech.